Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes

Seminars in Cancer Biology

Volumn 9, Issue 6, 1999, Pages 405-411

  Zur Hausen, Harald ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cervical cancer; E6 and E7 genes; Immortalization; Oncogene regulation; Papillomavirus

Indexed keywords

ALPHA INTERFERON; BETA ACTIN; BETA INTERFERON; CYTOKINE; DNA; ONCOPROTEIN; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; TAU INTERFERON; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANEUPLOIDY; CARCINOGENESIS; CELL GROWTH; CELL IMMORTALIZATION; GENE EXPRESSION; GENE MUTATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; REVIEW; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0033497345     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1999.0144     Document Type: Article

References (49)

1. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochem Biophys Acta Rev Cancer. 1288:1996.
2. McDougall JK. Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol. 186:1994;101-119.
3. Dürst M, Dzarlieva-Petrusevska RT, Boukamp P, Fusenig NE, Gissmann L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene. 1:1987;251-256.
4. Pirisi L, Yasumoto S, Fellery M, Doninger JK, DiPaolo JA. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol. 61:1987;1061-1066.
5. Kaur P, McDougall JK. Characterization of primary human keratinocytes transformed by human papillomavirus type 18. J Virol. 62:1988;1917-1924.
6. Münger K, Phelps WC, Bubb V, Howley PM, Schlegel R. The E6 and E7 genes of human papillomavirus type 16 are necessary and sufficient for transformation of primary human keratinocytes. J Virol. 63:1989;4417-4423.
7. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT. HPV 16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8:1989;3905-3910.
8. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, zur Hausen H. Structure and transcription of human papillomavirus type 18 and 16 sequences in cervical carcinoma cells. Nature. 314:1985;111-114.
9. Chen T-M, Pecoraro G, Defendi V. Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res. 53:1993;1167-1171.
10. Pereira-Smith OM, Smith JR. Expression of SV40 T antigen in finite lifespan hybrids of normal and SV40-transformed fibroblasts. Somatic Cell Genet. 7:1981;411-421.
11. Pereira-Smith OM, Smith JR. Genetic analysis if indefinite division in human cells: identification of four complementation groups. Proc Natl Acad Sci USA. 85:1988;6042-6046.
12. von Knebel Doeberitz M, Rittmüller C, Aengeneyndt F, Jansen-Dürr P, Spitkovsky D. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J Virol. 68:1994;2811-2821.
13. von Knebel Doeberitz M, Rittmüller C, zur Hausen H, Dürst M. Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 antisense RNA. Int J Cancer. 51:1995;831-834.
14. Watanabe S, Kanda T, Yoshiike K. Growth dependence of human papillomavirus 16 DNA-positive cervical cancer cell lines and human papillomavirus 16-transformed human and rat cells on the viral oncoproteins. Jpn J Cancer Res. 84:1993;1043-1049.
15. Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth AB. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Cancer Gene Ther. 2:1995;19-32.
16. Venturini F, Braspenning J, Homann M, Gissmann L, Sczakiel G. Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: anti-proliferative effects on HPV 16-transformed cells. Nucleic Acid Res. 27:1999;1585-1592.
17. Storey A, Oates D, Banks L, Crawford L, Crook T. Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16. Nucleic Acids Res. 19:1991;4109-4114.
18. Ting TM, Tang RC. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Cancer Res. 55:1995;4599-4605.
19. Chen Z, Kamath P, Zhang S, Weil MM, Shillitoe EJ. Effectiveness of three ribozymes for cleavage of an RNA transcript from human papillomavirus type 18. Cancer Gene Ther. 2:1995;263-271.
20. Seagon S, Dürst M. Genetic analysis of an in vitro model system for human papillomavirus type 16-associated tumorigenesis. Cancer Res. 54:1994;5593-5598.
21. zur Hausen H. Intracellular surveillance of persisting viral infections: human genital cancer resulting from failing cellular control of papillomavirus gene expression. Lancet. 2:1986;489-491.
22. zur Hausen H. Papillomaviruses in anogenital cancer: a model to understand the role of viruses in human cancers. Cancer Res. 49:1989;4677-4681.
23. Huibregtse JM, Scheffner M. Mechanisms of tumor suppressor protein inactivation by the human papillomavirus E6 and E7 oncoproteins. Semin Virol. 5:1994;357-367.
24. zur Hausen H. Papillomaviruses causing cancer: the evasion from host cell control marks early events in carcinogenesis. J Nat Cancer Inst. 1999.
25. White AE, Livanos EM, Tlsty TD. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 8:1994;666-677.
26. Liu X, Han S, Baluda MA, Park NH. HPV oncogenes E6 and E7 are mutagenic in normal human keratinocytes. Oncogene. 14:1997;2347-2353.
27. Kessis TD, Conolly DC, Hedrick L, Cho KR. Expression of HPV 16 E6 or E7 increases integration of foreign DNA. Oncogene. 13:1996;427-431.
28. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396:1998;84-88.
29. Hashida T, Yasumoto S. Induction of chromosomal abnormalities in mouse and human epidermal keratinocytes by the human papillomavirus type 16 E7 oncogene. J Gen Virol. 72:1991;1569-1577.
30. Matlashewski G, Schneider J, Banks L, Jones N, Murray A, Crawford L. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J. 6:1987;1741-1746.
31. Crook T, Storey A, Almond N, Osburn K, Crawford L. Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells. Proc Natl Acad Sci USA. 85:1988;8820-8824.
32. Dürst M, Gallahan D, Jay G, Rhim JS. Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology. 173:1989;767-771.
33. Pei XF, Meck JM, Greenbalgh D, Schlegel R. Cotransfection of HPV-18 and v-fos DNA induces tumorigenicity of primary human keratinocytes. Virology. 196:1993;855-860.
34. Soto U, Das BC, Lengert M, Finzer F, zur Hausen H, Rösl F. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex. Oncogene. 18:1999;3187-3198.
35. Reznikoff CA, Yeager TR, Belair CD, Salevieva E, Puthenveettil JA, Stadler WM. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not in E7, transformed human uroepithelial cells. Cancer Res. 56:1996;2886-2890.
36. Scott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, Peters G. The alternative product from the human CDK2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:1998;5001-5014.
37. Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV 16 E7 protein. Genes Dev. 11:1997;2090-2100.
38. Jones DL, Alani RM, Münger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 11:1997;2101-2111.
39. Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW, Jansen-Dürr P. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene. 13:1996;2323-2330.
40. Bosch FX, Schwarz E, Boukamp P, Fusenig NE, Bartsch D, zur Hausen H. Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa-fibroblast hybrid cells. J Virol. 64:1990;4743-4754.
41. Dürst M, Bosch FX, Glitz D, Schneider A, zur Hausen H. Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV positive human cell lines. J Virol. 65:1991a;796-804.
42. Dürst M, Bosch F, Glitz D, Schneider A, zur Hausen H. Inverse relationship between HPV 16 early gene expression and cell differentiation in nude mice epithelial cysts and tumors induced by HPV positive human cell lines. J Virol. 65:1991b;796-804.
43. Stoler MH, Rhodes CR, Whitbeck A, Wolinske SM, Chow LT, Broker TR. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol. 23:1992;117-128.
44. Rösl F, Das BC, Lengert M, Geletneky K, zur Hausen H. Antioxidant-induced changes in AP-1 composition result in a selective suppression of human papillomavirus transcription. J Virol. 71:1997;362-370.
45. Smits PHM, Smits HL, Minnaar R, Hemmings BA, Mayer-Jaekel RE, Schuurman R, van der Noordaa J, ter Schegget J. The trans-activation of the HPV 16 long control region in human cells with a deletion in the short arm of chromosome 11 is mediated by the 55kDa regulatory subunit of protein phosphatase 2A. EMBO J. 11:1992;4601-4606.
46. Arbeit JM, Münger K, Howley PM, Hanahan D. Neuroepithelial carcinomas in mice transgenic with human papillomavirus type 16 E6/E7 ORFs. Am J Pathol. 142:1993;1187-1197.
47. Ronco LV, Karpova AY, Vidal M, Howley PM. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:1998;2061-2072.
48. De Marco F, Manni V, Guaricci N, Muller A, Marcante ML. Induction of apoptotic cell death by IFNbeta on HPV-16 transformed human keratinocytes. Antiviral Res. 42:1999;109-120.
49. Johnson JA, Hochkeppel HK, Gangemi JD. IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoproteinexpression. J Interferon Cytokine Res. 19:1999;1107-1116.